Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study

NCT00706576 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT00706576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00706576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study
Lead sponsor
University of Missouri-Columbia
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer